Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
The Beauty Health Company
SKIN
NASDAQ·Consumer Defensive·Household & Personal Products·Mkt cap $93.0M
$0.73
▲ +1.11%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$0.55 - $2.69
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 66.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Proprietary HydraFacial technology with strong brand recognition and market leadership
- Recurring revenue model through consumable serums and treatment solutions
- Integrated digital ecosystem connecting providers and consumers for personalized experiences
- Expanding product portfolio addressing multiple beauty and wellness categories
- Global distribution network and established relationships with aesthetic practitioners
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Rising consumer demand for non-invasive aesthetic treatments and professional skincare
Value
Deep value opportunity - significant discount to Household Products peers
Momentum
Falling
-20.7% over 3m
Quality
Excellent
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying SKIN right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: May 6, 2026
MAY 7, 2026
Reported EPS of -$0.05 vs -$0.09 consensus (+44.4% surprise). Revenue of $64.9M vs $66.3M expected (-2.1%).
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+44.4%
Next: May 6, 2026
Revenue trend · last 8Q
—
—
-14%
-15%
-14%
-10%
-1%
-7%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$90.6M
$78.8M
$83.5M
$69.6M
$78.2M
$70.7M
$82.4M
$64.9M
Margins · last 8Q
Gross
—
Operating
—
Profit
-10.2%
Wall Street consensus
3 analysts · 33% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
33%
Hold
67%
Sell
0%
Median Price Target
$1.50
▲ +106.7% vs $0.73
Latest: Roth Capital · $2.00 · May 20, 2026
2 analysts covering